Market Access News | pharmaphorum

News

Amgen cuts US price of cholesterol drug by 60%

Amgen is cutting the US price of its cholesterol drug Repatha by 60%, following a similar decision by rivals Sanofi and Regeneron earlier this year.

News

Roche claims US approval for novel flu treatment

The US FDA has given a green light to a new influenza treatment from Shionogi and Roche that has the first new mechanism of action in more than two decades.

News

Teva slumps after Express Scripts funds migraine rivals in U...

A major prescription benefit manager in the US will not reimburse Teva’s preventative migraine drug Ajovy (fremanezumab), in an effort to cut costs.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

US blood pressure drug price doubles following shortages

Prices of the generic blood pressure drug valsartan rose more than any other in the US following a recall of much of the drug’s supply, according to press reports.

News

Samsung Bioepis' Humira biosimilar launches in EU

Samsung Bioepis has become the latest biosimilars company to confirm it has launched a cheaper near-copy of AbbVie’s Humira inflammatory diseases blockbuster, after its European patent expi

News

Billions up for grabs as EU patent on AbbVie's Humira expire...

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market.

Amgen cuts US price of cholesterol drug by 60%

Roche claims US approval for novel flu treatment

Teva slumps after Express Scripts funds migraine rivals in U...

US blood pressure drug price doubles following shortages

Samsung Bioepis' Humira biosimilar launches in EU

Billions up for grabs as EU patent on AbbVie's Humira expire...

Precision medicine in action, with Cary Claiborne

How to meet your physicians where they are online

News

Editor's Picks